1. Zheng-Xiang L. Development of Cardiac Valve Disease Treatment. Ling Nan Angiocardiopathy Magazine. 2010;201(05):343–51.
2. Dong L, Xu Jian P, Shi Ying K. Phasal Progress of Study on the Anticoagulation Individualization and Low Anticoagulation Standard after Valve Disease Sugery. Chin J Clin Thorac Cardiovasc Surg. 2013;2013(01):1–2.
3. Shah SG, Barnett J, Kuljis J, Hone K, Kaczmarski R. Factors determining patients' intentions to use point-of-care testing medical devices for self-monitoring: the case of international normalized ratio self-testing. Patient Prefer Adherence. 2013;2013(7):1–14.
4. Bussey HI, Linn WD. Warfarin and aspirin after heart-valve replacement. N Engl J Med. 1994;330(7):508–9.
5. Butchart EG, Payne N, Li HH, Buchan K, Mandana K, Grunkemeier GL. Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg. 2002;123(4):715–23. 2002-04-01.